Siemens Healthcare and Thermo Fisher Announce New Strategic Relationship in Molecular Testing
April 07 2016 - 5:00AM
Business Wire
- Siemens integrates Thermo Fisher’s
real-time PCR System into the VERSANT® kPCR Molecular
Solution
- Siemens to feature the new solution
at the European Congress of Clinical Microbiology and Infectious
Disease in Amsterdam
ECCMID-- In a joint effort to provide customers with one of the
most advanced solutions for molecular testing, Siemens Healthcare
and Thermo Fisher Scientific today announce a new strategic
relationship that includes the integration of Thermo Fisher
Scientific’s real-time PCR system into Siemens’ VERSANT® kPCR
Molecular Solution. The combined workflow will offer laboratories
Siemens’ complete molecular testing solution, which helps ensure
leading-edge performance from extraction through detection. Siemens
will display the entire system during the European Congress of
Clinical Microbiology and Infectious Disease in Amsterdam, The
Netherlands, April 9-12.
Thermo Fisher has brought to market easy-to-use, real-time PCR
instruments. Designed for mid-throughput, these new systems provide
ideal solutions for all users who need a high-performance
instrument with features for maximum experiment control. Adding
Thermo Fisher’s real-time PCR system to the VERSANT kPCR Molecular
Solution brings a new level of innovation to the market by
providing more flexibility and customization to the molecular
laboratory workflow.
“Through our molecular diagnostics systems, we offer a total
solution for accurate diagnosis and monitoring,” says Fernando
Beils, Head of Molecular Diagnostics, Siemens Healthcare. “We are
excited to strengthen our dedication to molecular laboratory
innovations through our partnership with Thermo Fisher
Scientific.”
“This agreement underscores our commitment to work with leading
molecular diagnostic organizations that share our vision to develop
advanced laboratory solutions,” said Drew Burch, Head of
Licensing and Commercial Supply for Thermo Fisher Scientific. “We
are excited to collaborate with Siemens in support of its VERSANT
kPCR Molecular Solution as we work to expand our partnerships in
the diagnostics space.”
Stop by Siemens’ booth 51 and Thermo Fisher’s booth 67a at
ECCMID to learn more.
VERSANT is a trademark of Siemens Healthcare Diagnostics Inc. or
its affiliates. All other trademarks are properties of their
respective owners. Product availability varies by country.
Siemens AG (Berlin and Munich) is a global technology
powerhouse that has stood for engineering excellence, innovation,
quality, reliability and internationality for more than 165 years.
The company is active in more than 200 countries, focusing on the
areas of electrification, automation and digitalization. One of the
world’s largest producers of energy-efficient, resource-saving
technologies, Siemens is No. 1 in offshore wind turbine
construction, a leading supplier of gas and steam turbines for
power generation, a major provider of power transmission solutions
and a pioneer in infrastructure solutions as well as automation,
drive and software solutions for industry. The company is also a
leading provider of medical imaging equipment – such as computed
tomography and magnetic resonance imaging systems – and a leader in
laboratory diagnostics as well as clinical IT. In fiscal 2015,
which ended on September 30, 2015, Siemens generated revenue of
€75.6 billion and net income of €7.4 billion. At the end of
September 2015, the company had around 348,000 employees worldwide.
Further information is available on the Internet at
www.siemens.com.
Thermo Fisher Scientific Inc. (NYSE:TMO) is the world
leader in serving science, with revenues of $17 billion and
approximately 50,000 employees in 50 countries. Our mission is to
enable our customers to make the world healthier, cleaner and
safer. We help our customers accelerate life sciences research,
solve complex analytical challenges, improve patient diagnostics
and increase laboratory productivity. Through our premier brands –
Thermo Scientific, Applied Biosystems, Invitrogen, Fisher
Scientific and Unity Lab Services – we offer an unmatched
combination of innovative technologies, purchasing convenience and
comprehensive support.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160407005325/en/
Siemens AGLance Longwell,
+1-610-448-6341lance.longwell@siemens.comorThermo Fisher Scientific
Inc.Mauricio Minotta,
+1-760-929-2456mauricio.minotta@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024